- Home
- HXHX vs ASBP Comparison
HXHX vs ASBP Comparison
Compare HXHX & ASBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HXHX | ASBP |
|---|---|---|
| Founded | 2003 | 2021 |
| Country | China | United States |
| Employees | 85 | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.8M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HXHX | ASBP |
|---|---|---|
| Price | $0.45 | $6.06 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 69.0K | ★ 16.8M |
| Earning Date | 05-20-2026 | 04-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $1.96 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.33 | $0.05 |
| 52 Week High | $2.11 | $7.05 |
Technical Indicators
Market Signals| Indicator | HXHX | ASBP |
|---|---|---|
| Relative Strength Index (RSI) | 41.47 | 77.04 |
| Support Level | $0.44 | $0.21 |
| Resistance Level | $0.57 | N/A |
| Average True Range (ATR) | 0.05 | 0.56 |
| MACD | -0.01 | 0.52 |
| Stochastic Oscillator | 27.07 | 85.30 |
Price Performance
Historical ComparisonAbout HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About ASBP Aspire Biopharma Holdings Inc.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.